Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial
| Izdano u: | Nature Cancer 4(2023)1, S. 96-107 |
|---|---|
| Glavni autori: | , , , |
| Format: | Članak |
| Jezik: | English |
| Izdano: |
2023
|
| Teme: | |
| Online pristup: | https://doi.org/10.1038/s43018-022-00503-w |
| Povezana djela: | In:
Nature Cancer |
| Opis djela: | Exemplar/Standort: Open Access |
|---|---|
| Digitalni identifikator objekta: | 10.1038/s43018-022-00503-w |
| Signatura: | Open Access |